LOS ANGELES, Jan. 19, 2012 /PRNewswire/ -- BG Medical
Technologies, Inc. (OTC:RIGH) announces the successful completion
of a reverse merger with RightSmile, Inc. BG Medical, headquartered
in Los Angeles, California, will
operate under the leadership of a new management team led by Chief
Executive Officer, Angel
Stanz. The Company is working with counsel to file the
appropriate documents with FINRA to promptly complete its formal
name and symbol change.
BG Medical Technologies, Inc. has exchanged 100% of its
outstanding shares for 4 million shares of preferred stock and 200
million shares of restricted common stock. Currently the
Company does not have authorized shares remaining to issue BG
Medical required stock and will look to increase its authorized
shares to issue restricted shares to BG Medical. BG Medical plans
to use stock options as incentives to attract seasoned talent to
its workforce. This will enable the Company to accelerate
development and expedite its future business plans. BG Medical will
also resume the task of uplisting the Company to the OTC Bulletin
Board by engaging the team that began an audit in 2010.
BG Medical is a technology and services provider for the medical
cannabis industry. The company delivers an educational
consumer experience through an expanding suite of software and
services. BG Medical's flagship brand, BudGenius.com, is an online
portal providing medicine matching and directory services enabling
patients to select and locate the most effective cannabis for their
ailments. BG Laboratories provides potency, pesticide, and
contaminant analysis reporting for medical cannabis. BG Medical has
provided testing services for over 240 cannabis dispensaries,
farmers, and product manufacturers. BudGenius.com receives over
2,000 visits daily from patients looking to locate applicable
medicine for their medical needs.
The Company completed 3,000 cannabis tests for year ending 2011,
and projects over 10,000 cannabis tests for year 2012. BG Medical
will capitalize on new 2012 revenue streams in targeted advertising
programs for web and video, the launch of an on-demand video
network, software licensing revenue, and patient loyalty programs.
BG Medical adds $662,000 in assets to
the current balance sheet of the public entity as well as projected
revenues for 2012 upwards of $6,500,000. Full revenue stream projections will
be released on or prior to February
1st.
BG Medical Technologies does not sell, grow, harvest, cultivate,
nor distribute medical cannabis.
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
Contact:
Angel Stanz
Chief Executive Officer
pr@budgenius.com
(855) 723-3283
SOURCE BG Medical Technologies, Inc.